Dr. Alexander Anatolievich Kamnev is a leadind scientist in the Institute of Biochemistry and Physiology of Plants and Microorganisms Russian Academy of Sciences Russia He received his MS chemistry 1980 Saratov State University Russian Federation; PhD physical chemistry 1992 DSc physical chemistry 2002 Saratov State University His specialization in the main field: Molecular mechanisms of plantbacterial interactions and signalling; plantgrowthpromoting rhizobacteria; Azospirilla Other fields:Physicochemical aspects of rhizosphere processes involving metal ions He is the Member of the Russian Microbiological Society FEMS Constituent Society; Russian Society of Biochemists and Molecular Biologists FEBS Constituent Society He has 75 papers in refereed journals and 132 full papers and abstracts in communications to scientific meetings.

Development and applications of novel spectroscopic and nuclearchemistry approaches in biochemical and microbiological research.

Prof. Rogatsky serves as the Editor-in-Chief for the Journal of Analytical and Bioanalytical Techniques (OMICS publishing group). During the last 10 years (from 2005) he has published over 30 scientific papers in per-reviewed journals (mostly as the first author) and has presented over 50 posters and lectures. Overall, he has made more than a hundred scientific presentations and publications. Eduard completed his M.Sc. in physical chemistry at Belarus State University (former USSR) in 1990. He completed his PhD in bioanalytical chemistry (Bar-Ilan University, Israel) in 1998. At the end of 1999, he started his post-doctorate at Albert Einstein College of Medicine and became a faculty member since 2001 and was a mass spectrometry director at the Biomarker Analytical Resource Core. From October 2015 Dr. Rogatsky is a supervisor of the Chemical Threat Laboratory in the Division of Environmental Health Sciences at Wadsworth Center, Albany NY, USA and continue to be an Adjunct Professor at Albert Einstein College of Medicine.

Design and development ultra-sensitive LC/MS analytical assays of clinical biomarkers and metabolites. LC/MS analysis of peptide hormones and proteins and absolute quantitation using isotope dilution assays. Design and development of multi-dimensional chromatography platforms and investigation of physical processes during column switching and mixing. Investigations of column selectivity under different conditions. Optimization of LC/MS for use of UPLC and fused core columns.

Abdeen Mustafa Omer (BSc, MSc, PhD) is an Associate Researcher at Energy Research Institute (ERI). He obtained both his PhD degree in the Built Environment and Master of Philosophy degree in Renewable Energy Technologies from the University of Nottingham. He is qualified Mechanical Engineer with a proven track record within the water industry and renewable energy technologies. He has been graduated from University of El Menoufia, Egypt, BSc in Mechanical Engineering. His previous experience involved being a member of the research team at the National Council for Research/Energy Research Institute in Sudan and working director of research and development for National Water Equipment Manufacturing Co. Ltd., Sudan. He has been listed in the book WHO'S WHO in the World 2005, 2006, 2007 and 2010. He has published over 300 papers in peer-reviewed journals, 200 review articles, 7 books and 150 chapters in books.

Environmental Analytical Technique

After completion of his postdoctoral training at University of Texas MD Anderson Cancer Center, Prof. Gautam Sethi joined Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore in 2008 as an Assistant Professor and was promoted to Associate Professor in 2015. The focus of his research over the past few years has been to elucidate the mechanism(s) of activation of oncogenic transcription factors such as NF KB/STAT3 by carcinogens and inflammatory agents and the identification of novel inhibitors of these proteins for prevention of and therapy for cancer. From traditional Chinese and Indian medicinal plants, his group has identified numerous small molecules that can suppress various pro-tumorigenic signaling cascades involved in cancer initiation and promotion. The novel findings of his research work have so far resulted in more than one fifty scientific publications in high impact factor peer reviewed journals and several international awards. He currently serves as an Academic Editor for prestigious PLOS One journal and ad-hoc reviewer for several other international journals.

Pharmacology,Drug analysis

Dr. Rossitza Lazova is an Associate Professor at Dermatology and Pathology in the Yale University. She completed her M.D. at Higher Medical University Bulgaria in the year 1985.n particular. Dr. Lazova is on the editorial board.

Spitz nevi, Spitzoid melanocytic neoplasms, Malignant melanoma, Melanocytic nevi on special anatomic sites.

Dr Sergey Suchkov, MD, PhD was born in 11.01.1957, a researcher-immunologist, a clinician, graduated from Astrakhan State Medical University, Russia, in 1980. Suchkov has been trained at the Institute for Medical Enzymology, The USSR Academy of Medical Sciences, National Center for Immunology (Russia), NIH, Bethesda, USA, and British Society forImmunology to cover 4 British university facilities. Since 2005, Dr Suchkov has been working as Professor of I.M. Sechenov First Moscow State Medical University and of A.I.Evdokimov Moscow State Medical & Dental University. From 2007, Suchkov is the First Vice-President and Dean of School of PPPM Politics and Management of the University of World Politics and Law. In 1991-1995, Dr Suchkov was a Scientific Secretary-in-Chief of the Editorial Board of the Interna-tional Journal“Biomedical Science” (Russian Academy of Sciences and Royal Society of Chemistry, UK) and TheInternational Publishing Bureau at the Presidium of the Russian Academy of Sciences. In 1995-2005, Suchkov was a Director of the Russian-American Program in Immunology of the Eye Dis-eases.Dr Suchkov is a member of EPMA (European Association of Predictive, Preventive and Person-alized Medicine,Brussels-Bonn), a member of the NY Academy of Sciences, a member of the Editorial Boards for Open Journal of Immunology, EPMA J., and Personalized Medicine Universe, and others. Dr Suchkov is known as a co-author of the Concept of post-infectious clinical and immunological syn-drome, co-author of a concept of abzymes and their impact into the pathogenesis ofautuimmunity conditions, and as one of the pioneers in promoting the Concept of PPPM into a practical branchof health services. Now r Suchkov is a Chair of Dept for Personalized & Translational Medicine, and Director, Center for Personalized & Translational Reproductology, I.M.Sechenov First Moscow State Medical University. Prof Sergey Suchkov, MD, PhD Chair, Dept for Personalized and Translational Medicine, Director, Center for Personalized Reproductology & Pediatrics, I.M.Sechenov First Moscow State Medical University, Moscow, Russia Member, EPMA, Brussels, EU Member, PMC, Washington, DC, USA Member, ISPM, Tokyo, Japan Member, New York Academy of Sciences Member, ACS, USA Member, AHA, USA Member, AMEE, Dundee, UK Secretary General, UCC, Cambridge, UK

Clinical Chemistry

Dr Makhafola is currently the General Manager: Research & Development at Mintek. He worked as Lecturer in Analytical Chemistry at Technikon Northern Gauteng (now called Tshwane University of Technology) and University of Venda. In 2004 was appointed Director: Quality Assurance at Border Technikon (now called Walter Sisulu University). Dr Makhafola was the Director: Quality Assurance at the University of Venda until he joined University of Kwa-Zulu Natal as the Director Quality Promotion & Assurance in July 2010, part of his responsibility was to lead the World University Rankings project.

Analytical Technique

Dr. Caglar is an Associate Professor at the Istanbul University, Faculty of Pharmacy Department of Analytical Chemistry. She conducted post-doctoral research at Medical Center of Munich University, Institute of Laboratory Medicine Laboratory of BioSeparation with a main focus of hyphenation of mass spectrometry with on-line sample processing between the years 2011-2013. She studied Chemical Engineering and had Ph.D. and M.Sc. degrees at Istanbul University, Institute of Health Sciences Department of Analytical Chemistry on drug analysis in pharmaceutical formulations and biological fluids by spectrophotometry and liquid chromatography.

Dr. Caglar has interest in on-line sample processing coupled with liquid chromatography tandem mass spectrometry in the pharma/clinical arena, focusing on biological fluids analysis. She has researches in drug analysis in biological fluids by liquid chromatography mass spectrometry, on-line solid phase extraction coupled liquid chromatography, multidimensional chromatography, spectrophotometry and spectrofluorimetry, also degradation, pharmacokinetic and validation studies.

Dr. Lingzhi Wang is a Senior Research Scientist in the Experimental Therapeutics Program and Deputy Head of Drug Analysis & Pharmacokinetics Core (DAPC) of the Cancer Science Institute of Singapore, National University of Singapore (NUS). Currently, he is also an Associate Professor in the Department of Pharmacology of Yong Loo Lin School of Medicine, NUS.

Drug Analysis, Pharmacological activity, DNA Analysis

Professor Jammi Srinivasa Rao and it was a scientific journal associated with The Vibration Institute of India (TVII). Professor J.S. Rao is the current Editor-in-Chief of JVET and he is also the founding and current President of TVII.

Analytical Techniques,Separation Techniques

Prof. Peter de B. Harrington is director for the Center for Intelligent Chemical Instrumentation in Ohio University, USA. He has completed his Ph.D in chemistry from University of North Carolina and extends his eminence as professor of Chemistry and Biochemistry in Ohio University.

His main research focuses on Mass Spectrometry and ion mobility spectrometry, his group Centre for Intelligent Chemical Instrumentation is interested in coupling chemo metric methods with ion mobility and mass spectrometers, so that the chemo metric methods are transparent to the user and so that the instrument exhibits intelligent behaviour. An intelligent instrument furnishes user- or problem-defined information as opposed to data that must be interpreted by a scientist. His group is developing algorithms that perform real-time signal processing, modelling, and interpretation

Chenzhong Li, the principal investigator of the nanobioengineering/bioelectronics lab, in the Biomedical Engineering Department at Florida International University.Dr.Li received his M.Sc and Ph.D from Kumamoto University in Japan . Dr. Li served as a post-doctoral research associate at the university of British Columbia and as professional research associate at the University of Saskatchewan and Adnavance Technologies, Inc.

Dr. Li has made significant impact in the areas of clinical point-of-care diagnostics, biodefense and environmental related applications of biosensor technology, specifically, sensors incorporating whole cells and those used for disease-related biomarker analysis. His research employs the interfacing of bioengineering with cell electronics, bio-nano conjugations, functional nanomaterials, and device fabrication.

Dr. Schöneich is the Takeru Higuchi Professor for Bioanalytical Chemistry and Chair of the Department of Pharmaceutical Chemistry at The University of Kansas. He received his Diploma in Chemistry from the Free University Berlin, Germany, in 1987. Between 1987 and 1991 he worked in the Department of Radiation Chemistry at the Hahn-Meitner Institute for Nuclear Research in Berlin, Germany. He received his Ph.D. in Chemistry in 1990 from the Technical University Berlin, Germany. He joined the Department of Pharmaceutical Chemistry at The University of Kansas as a post-doctoral fellow in 1991, and as a faculty member in 1992; in 2004, he was a Visiting Professor at the ETH Zürich, Switzerland.

Professor Schöneich's research focusses on oxidative post-translational modifications of proteins in vitro and in vivo, and the consequences of such modifications for the development of protein therapeutics and biological systems. Oxidative post-translational modifications are generally carried out by reactive oxygen species and/or reactive nitrogen species. In vivo, such oxidative modifications accompany physiological disorders associated with biological aging or disease. Importantly, only selected proteins suffer oxidative modifications in vivo, which may be the result of chemical selectivity, protein structure, the rates of protein turnover, and/or specific protein-protein interactions. In vitro, i.e. in pharmaceutical formulations, protein oxidation presents an important stability problem. We are interested to generate a database which relates oxidation sensitivity to specific structural elements of proteins. With such a database at hand, we can potentially predict the stability of new protein products, facilitating pharmaceutical development. To achieve such a database, we are studying oxidative protein stability for proteins in (a) solution, (b) in polymeric matrices, and (c) in the solid state.

Dr. Jun Li is professor at Kansas State University, USA. He has completed his Ph.D in chemistry from Princeton University and extends his eminence as professor of Chemistry in Kansas State University.

Nanoscience and nanotechnology, growth of nanomaterials (carbon nanotubes, semiconductor nanowires, nanoparticles) and fabrication of micro-/nano- devices for analytical, biomedical, electronics, and energy conversion and storage applications.

Professor Pandey earned his Ph.D. from the University of Pune, National Chemical Laboratory in Pune, India. He is the president and CEO of the GD Pandey Ayurvedic University, based in New Jersey. He has a distinguished career in the biomedical sciences and pharmaceutical research spanning over 40 years with positions at the National Cancer Institute (US), Abbot Laboratories, Lyphomed. Till June 2011 he was the Chairman/Chief Executive Officer and founder of Xechem, Inc., XetaPharm, Inc., Xechem (India) Pvt Ltd, and chairman of the board and CEO of Xechem International, Inc.

Phytomedicines, also known as herbal products are playing a major role in the treatment of diseases, for which there have been no medicines in the western world.Advances in new bioassay methods and analytical technologies, such as High Performance Liquid Chromatography (HPLC), and Liquid Chromatography-Mass Spectrometry (LC-MS) are important in the identification of various components in extracts to prepare a standardized product.

Kaveh Edalati is a Professor of Materials Science at Kyushu University, Japan. He had completed his M.Sc. in Materials Engineering- Identification & Selection of Metallic Materials, Tehran University, Faculty of Engineering, Iran and PhD in Materials Physics and Chemistry, Kyushu University, Japan.

Analytical chemistry, Materials Science, Materials Physics and Chemistry.

Dr. habil Raluca-Ioana Stefan-van Staden – born on 16th of July 1969 in Campulung-Muscel, Romania is a Senior Researcher and Scientific Director of National Institute of Research for Electrochemistry and Condensed Matter, Romania, and Professor (promoter for PhD students) at University Politehnica Bucharest. The author and co-author of more than 240 articles (with an h factor of 29), in fields like electrochemical sensors, process analytical technology and flow systems, and spectrometry, of three book: “Quality and reliability in analytical chemistry” (CRC Press), “Electrochemical Sensors in Bioanalysis” (Marcel Dekker, Inc) and “Laboratory Auditing for Quality and Regulatory Compliance” (Taylor and Francis) as well as of numerous chapters in books most of them related to sensors technologY.

Analytical Chemistry, Electrochemistry,Biochemistry and Biotechnology.

Dr Nikolaos E. Labrou received his BSc degree in Chemistry from the University of Patras, Greece (1987-1991) and his PhD in Enzyme Biotechnology from the Agricultural University of Athens (1992-1996). He has conducted postdoctoral research, as Marie Curie fellow, in Leeds UK (1996-1998) and then at Agricultural University of Athens (1998-2001). Dr Labrou is currently full Professor with tenure and Director of the Enzyme Technology Lab at the Agricultural University of Athens. Professor Labrou has authored more than 135 peer-reviewed articles in leading international journals and has published two books (Springer). Dr. Labrou is an Editor-in-Chief for the journal Recent Patents on Biotechnology, Associate Editor for the Protein Journal (Springer) and he is on the Editorial Board of several scientific journals (Enz. Microb. Technol; Protein & Peptide Let., etc).

His research takes place where molecular enzymology and analytical chemistry meet and covers aspects of the entire range from pure to applied science.

Dr. (Ms) T.Theivasanthi of Kalasalingam University doing research in nanomaterials / nanotechnology; has 15 years of teaching experience; published many research articles/ books and h-index 10; life member of Indian Science Congress Association and Magnetics Society of India; member of International Association of Advanced Materials; serving as Editorial Board Member/ reviewer for some scientific journals; lead editor in JNNN special issue (SAGE Publications, UK); achieved many awards/ honours/ recognitions including - Madurai Women Achievers Award - 2013, Motivational Award - 2015 and 2015 Women’s Day Award of St.Annes College; achieved World Record in LIMCA Book of Records-2015 for nanotechnology invention “World’s first superparamagnetic plants materials” – named “Santhi Particles”, World Record– 2016 for innovative products "The World’s lowest priced graphene" & "World’s Smallest Particles of Vegetables" and World Record– 2017 for the invention "The World’s Smallest Anti-Viral Plant Particles". Other innovative products- Superparamagnetic lead nanoparticles, semiconducting lead Nanoparticles, Low cost-mass production of graphene, agricultural nanofertilisers, vegetable powder for diabetes, plants materials for diabetes & psoriasis and nanoparticles for treatment of EBOLA, DENGUE, HIV & H1N1 virus infection. Govt. of India shows interests to develop her inventions for the benefits of public; since Dec-2014, she has delivered lectures (more than 120) in International / National scientific conferences, foreign countries and renowned institutes like National Institute of Technology, Anna University, Central University of all over India; she delivered Motivational Lectures for women, students and staff of institutes / Multi-national corporate companies (Cognizant Technologies); Artha Nyana Academy (Malaysia), Intelligent Society of Malaysia etc. NanoDigest, Economic Times and Telegraph have published news about her research; Thanthi TV, All India Radio, Minnal FM (Malaysia) and Bernama TV (Malaysia) have broadcasted her interviews.

Her research interest in innovative products- Superparamagnetic lead nanoparticles, semiconducting lead Nanoparticles, Low cost-mass production of graphene, agricultural nanofertilisers, vegetable powder for diabetes, plants materials for diabetes & psoriasis and nanoparticles for treatment of EBOLA, DENGUE, HIV & H1N1 virus infection.

Mohamed Eddouks is Professor at Moulay Ismail University, Faculty of Sciences and Techniques Errachidia, Morocco. He is a researcher in Physiology and Pharmacology with a Master Degree in Metabolic and Molecular Endocrinology from University of Paris vi, a specialized certificate in Endocrine Pharmacology from University of Paris vii and PhD degrees in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his post-doctoral fellowship at Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 16 years on medicinal plants. His work on antidiabetic and antihypertensive plants is well recognized globally. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension. His contribution to this field includes four international books and more than 80 peer-reviewed articles and book chapters of international repute. He is Guest Editor of American Journal of Pharmacology and Toxicology, Lead Guest Editor of an annual special issue published by Evidence-Based and Complementary Alternative Medicine, Regional Editor of the Following journals: American Journal of Food Technology, Journal of Applied Sciences, Trends in Applied Sciences Research and Singapore Journal of Scientific research, Member of Editorial Board of several international journals. He has been honored with the first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development and the first Prize of the Federation of Arab Scientific Councils in 2016. He has been the Dean of Polydisciplinary Faculty of Errachidia from 2008 to 2012.

Physiology and Pharmacology, Metabolic and Molecular Endocrinology and Analytical chemistry.

Dina A. Ghroaba is a Clinician Genetic and Genomic Physician Scientist and an internationally esteemed author who has been serving as an editorial board member of repute journals. She had completed her M.Sc. in Biochemistry- Molecular Diagnosis of Genetic Diseases from the Faculty of Science- Ain Shams University and is currently pursuing Medicine as well as PhD studies. Her researches aim to serve Diagnostic Genetics and Gene-Based Therapeutics.

Diagnostic Genetics, Precision Medicine, Regenerative Medicine and Gene-Based Therapeutics

Shimaa Mohamed Elsaeed Hamouda is aProfessor of Polymer Chemistry at Egyptian Petroleum Research Institute (EPRI) Egypt.

Analytical chemistry, Recycling of PET waste, Hydrogel, Polymeric corrosion inhibitor, Polyester